Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
Active, not recruiting · NCT04815187 · Registry updated 2025-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease | Ear Diseases, Hypersensitivity, Immediate, Meniere disease, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, Rhinitis, Allergic, Signs and Symptoms, Vertigo, endolymphatic hydrops, immune system disorder, inner ear disorder, nasal disorder, nervous system disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, vestibular disorder | Active, not recruiting | Phase 4 | 2025-03-18 | NCT04815187 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cures Within Reach | 9 |
| House Ear Institute | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| House Ear Clinic | Los Angeles | United States | 1 |
| House Institute Foundation | Los Angeles | United States | 1 |